Skip to main content
Clinical Trials/NCT05728580
NCT05728580
Recruiting
N/A

Risk Factor for Percutaneous Coronary Intervention in the Beijing Friendship Hospital

Beijing Friendship Hospital1 site in 1 country10,000 target enrollmentDecember 31, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
Beijing Friendship Hospital
Enrollment
10000
Locations
1
Primary Endpoint
MACCE
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this study is to discover the potential risk factors related percutaneous coronary intervention. It aims to stratify the risk of PCI patients and discover the prognostic value of these risk fators.

Detailed Description

Coronary heart disease is the main cause of death worldwide. Ischemic heart disease is the most common cause of death. Percutaneous coronary intervention (PCI) is a very effective treatment for coronary heart disease, which can alleviate myocardial ischemia and reduce the mortality of patients with acute myocardial infarction. It is an important measure to treat coronary heart disease at present. However, the study found that the incidence of major adverse cardiac and cerebrovascular event (MACCE) after PCI was more than 10%, which could reach 20-30% in elderly patients. Therefore, the purpose of this study is to investigate the risk factors related to PCI and to intervene or change the treatment strategy as early as possible. Risk stratification was performed in these patients for improving the quality of life of patients, reducing medical costs, and improving the life expectancy of patients. Patients with PCI in Beijing friendship hospital are enrolled.The primary outcome is MACCE and all-cause mortality.

Registry
clinicaltrials.gov
Start Date
December 31, 2017
End Date
December 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age greater than or equal to 18 years at the time of admission to the hospital
  • PCI patients with coronary heart disease: according to the criteria interpreted in the 2011 American Guidelines for Percutaneous Coronary Intervention. The successful diagnostic criteria of PCI: residual stenosis of the treated vessel\<10% (preferably 0%), and the forward flow is TIMI grade 3, there is no dissection that affects the flow, no important side branch occlusion, no visible thrombus and peripheral embolism.

Exclusion Criteria

  • Patients who failed in PCI treatment;
  • Current known inability to follow instructions or comply with follow-up procedures.

Outcomes

Primary Outcomes

MACCE

Time Frame: These data is collected during follow-up for 5 years after discharge

defined as a composite of all cause mortality, any myocardial infarction (MI), any revascularization, stroke, and heart failure hospitalization

All-cause mortality

Time Frame: These data is collected during follow-up for 5 years after discharge

whether recidivation happened,whether other related disease happened

Study Sites (1)

Loading locations...

Similar Trials